Phase I Study of SYS6043 in Patients With Advanced/Metastatic Solid Tumors
Conjupro Biotherapeutics, Inc.
Conjupro Biotherapeutics, Inc.
K36 Therapeutics, Inc.
Yonsei University
Chinese University of Hong Kong
UroTrials Company (GmbH)
The Methodist Hospital Research Institute
National Institutes of Health Clinical Center (CC)
National Institutes of Health Clinical Center (CC)
National Institutes of Health Clinical Center (CC)
Alterome Therapeutics, Inc.
National Institutes of Health Clinical Center (CC)
National Institutes of Health Clinical Center (CC)
Amgen
UMC Utrecht
Nuvectis Pharma, Inc.
Psyence Australia Pty Ltd
ViroMissile, Inc.
Tianjin Medical University Second Hospital
Wake Forest University Health Sciences
University of Florida
Tizona Therapeutics, Inc
Essen Biotech
Essen Biotech
A2 Biotherapeutics Inc.
Angiex, Inc.
St. Jude Children's Research Hospital
Hospices Civils de Lyon
Bristol-Myers Squibb
White River Junction Veterans Affairs Medical Center
Mayo Clinic
University of Washington
Elephas
Icahn School of Medicine at Mount Sinai
Dysplasia Diagnostics Limited
RenJi Hospital
Var2 Pharmaceuticals
Elephas
OncoNano Medicine, Inc.
Calico Life Sciences LLC
GlaxoSmithKline
Sairopa B.V.
Centre Hospitalier Universitaire de Saint Etienne
Lahey Clinic
Jinling Hospital, China
University of Colorado, Denver
Pathos AI, Inc.
University of Texas Southwestern Medical Center
St. Jude Children's Research Hospital
Rondo Therapeutics
ImmunityBio, Inc.